Optimal Risk-Adapted Surveillance Strategies for NMIBC, Including Upper Tract Imaging
Optimal Risk-Adapted Surveillance Strategies for NMIBC, Including Upper Tract Imaging
复制标题
DOI：
10.1016/j.ucl.2013.01.013
复制
发表时间：
2013-05-01
影响因子：
2.4
通讯作者：
Steinberg, Gary D.
中科院分区：
文献类型：
--
作者：
Large, Michael C.;Cohn, Joshua A.;Steinberg, Gary D.
非肌层浸润性膀胱癌（NMIBC）占所有膀胱癌发病病例的约70%。NMIBC的财政负担继续增加，强调了对这种疾病进行有效的循证管理的重要性。共识准则在风险定义和管理建议方面各不相同。本文回顾了NMIBC的发病率和经济影响，并详细介绍了美国泌尿外科协会、膀胱癌国际咨询-欧洲泌尿外科协会和国家综合癌症网络提出的诊断、治疗和监测建议。建立和发展的实验室和影像学检查针对NMIBC的诊断和管理进行了讨论。
Non-muscle invasive bladder cancer (NMIBC) represents approximately 70% of all incident cases of bladder cancer. The financial burden of NMIBC continues to increase, underscoring the importance of efficient, evidence-based management of this disease. Consensus guidelines differ on risk definition and in management recommendations. This article reviews the incidence and financial impact of NMIBC and details the recommendations for diagnosis, treatment, and surveillance made by the American Urological Association, International Consultation on Bladder Cancer-European Association of Urology, and National Comprehensive Cancer Network. Established and developing adjunctive laboratory and imaging tests directed at diagnosis and management of NMIBC are also discussed.